PPIPT01880
Target Protein Information
| Protein_Name | STEAP1 protein |
|---|---|
| Protein_Sequence | MESRKDITNQEELWKMKPRRNLEEDDYLHKDTGETSMLKRPVLLHLHQTAHADEFDCPSELQHTQELFPQWHLPIKIAAIIASLTFLYTLLREVIHPLATSHQQYFYKIPILVINKVLPMVSITLLALVYLPGVIAAIVQLHNGTKYKKFPHWLDKWMLTRKQFGLLSFFFAVLHAIYSLSYPMRRSYRYKLLNWAYQQVQQNKEDAWIEHDVWRMEIYVSLGIVGLAILALLAVTSIPSVSDSLTWREFHYIQSKLGIVSLLLGTIHALIFAWNKWIDIKQFVWYTPPTFMIAVFLPIVVLIFKSILFLPCLRKKILKIRHGWEDVTKINKTEICSQL |
| Organism_Source | Homo sapiens |
| Functional_Classification | Metalloreductase |
| Cellular_Localization | Plasma membrane |
| Gene_Names | STEAP1 |
| UniProt_ID | Q9UHE8 |
| Protein-Protein Interaction Networks | |
Peptide Basic Information
| Peptide_Name | STEAP1_A0201 |
|---|---|
| Peptide_Sequence | LLLGTIHAV |
| Peptide_Length | 9 |
| Peptide_SMILES | CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)O)C(C)C |
| Chemical_Modification | None |
| Cyclization_Method | None |
| Linear/Cyclic | Cyclic |
| N-terminal_Modification | Free |
| C-terminal_Modification | Free |
| Amino_Acid_Distribution | |
|
|
|
Peptide Physicochemical
| Molecular_Weight | 936.16 |
|---|---|
| Aliphatic_Index | 216.66667 |
| Aromaticity | 0.00000 |
| Average_Rotatable_Bonds | 3.22222 |
| Charge_at_pH_7 | 0.08889 |
| Isoelectric_point | 7.55032 |
|---|---|
| Number_of_Hydrogen_Bond_Acceptors | 12 |
| Number_of_Hydrogen_Bond_Donors | 12 |
| Topological_Polar_Surface_Area | 345.03000 |
| X_logP_energy | -0.88500 |
Interaction Information
| Affinity | IC50=11.72 nM |
|---|---|
| Affinity_Assay | ProImmune REVEAL assay |
| PDB_ID | None |
| Type | Affinity ligand |
| Structure | |
Reference Information
| Document_Type | Patent |
|---|---|
| Title | IMMUNOGENIC HETEROCLITIC PEPTIDES FROM CANCER - ASSOCIATED PROTEINS AND METHODS OF USE THEREOF |
| Release_Year | 2021 |
| Patent_ID | US20210177955A1 |